Press Releases

Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 23, 2013 at 9:00 AM Eastern; Webcast Will Be Available

...

Read More

Emergent BioSolutions to Webcast Presentation at Bank of America Merrill Lynch 2013 Health Care Conference

...

Read More

Emergent BioSolutions Presents Preclinical Efficacy Data on ES414 Its Lead ADAPTIR Bispecific Therapeutic for Prostate Cancer

...

Read More

Emergent BioSolutions Reports Financial Results for First Quarter 2013

...

Read More

Emergent BioSolutions Participates in NATO Defense against Terrorism Workshop at the Counter Terror Expo in London

...

Read More

Emergent BioSolutions to Webcast Presentation at Credit Suisse First Annual Antibody Day

...

Read More

Emergent BioSolutions to Acquire Healthcare Protective Products Division of Bracco Diagnostics Inc.

...

Read More

Emergent BioSolutions Presents Efficacy Data on ES210; a Bispecific ADAPTIR Molecule for Treating Autoimmune Diseases

...

Read More

Emergent BioSolutions Announces Positive Preclinical Efficacy and PK Data for Its New Bispecific Adaptir Protein Therapeutic ES414 at AACR

...

Read More

Emergent BioSolutions to Expand Front Line CLL Clinical Trial of TRU-016 and Rituximab Based on Strong Patient Enrollment and Encouraging Early Clinical Data

...

Read More

Emergent BioSolutions to Release First Quarter 2013 Financial Results and Conduct a Conference Call on May 2, 2013

...

Read More

Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2012

...

Read More